More...
More...
More...
More...
Emlyn leads the policy development team at Cancer Research UK. His team is responsible for developing the charity's position on areas of public policy on a range of issues, including how Government can support a thriving research environment, how NHS cancer services are run and how charity laws should be reformed. His previous roles include policy positions at the Wellcome Trust, The Academy of Medical Sciences, and a secondment to the Office for Life Sciences to support the development of the Life Sciences Industrial Strategy. He is part of the first cohort of the Academy of Medical Sciences ‘Future Leaders in Innovation, Enterprise and Research’ (FLIER) programme.
For the Prime Minister to reach her ambitions of 3 in 4 cancer patients diagnosed early in the next 10 years, NHS staff shortages must be addressed.
NHS England has announced that it will invest £130m in new radiotherapy machines. Read why that investment is so important.
We explore our latest report showing that thousands of cancer patients are missing out on genetic tests for targeted cancer drugs.
Now that the Independent Cancer Taskforce has published its five-year strategy for cancer, we ask: what happens next?
Last Friday was the deadline to submit evidence to NHS England’s Cancer Taskforce – and we, like many others, put in a response. Read what it included.
The Government must keep its promise over high-quality gene tests for cancer patients
We take a look at what the recently published NHS ‘Five Year Forward View’ means for cancer care within the health service in England.
A look at a Government announcement to help fund some of our radiotherapy trials
As of Monday (1st April) the Government’s reform of the NHS became a reality, with the Health and Social Care…
Text from Cancer Research UK's News site by Cancer Research UK, is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License.
